邢丽妍
Lv1
100 积分
2022-08-02 加入
-
First-line zorifertinib for EGFR-mutant non-small cell lung cancer with central nervous system metastases: The phase 3 EVEREST trial
8天前
已完结
-
First-line zorifertinib for EGFR-mutant non-small cell lung cancer with central nervous system metastases: The phase 3 EVEREST trial
8天前
已完结
-
Angiogenesis and Pancreatic Cancer: Novel Approaches to Overcome Treatment Resistance
4个月前
已完结
-
Cancer statistics, 2024
4个月前
已完结
-
Alternating gemcitabine plus nab-paclitaxel and gemcitabine alone versus continuous gemcitabine plus nab-paclitaxel after induction treatment of metastatic pancreatic cancer (ALPACA): a multicentre, randomised, open-label, phase 2 trial
5个月前
已完结
-
Pyrotinib plus capecitabine for pa- tients with human epidermal growth factor receptor 2-positive breast cancer and brain metastases (PERMEATE):overall survival results from a multicenter, single-arm, two-cohort, phase 2 trial
6个月前
已关闭
-
Molecular subtype predicts incidence and prognosis of brain metastasis from breast cancer in SEER database
7个月前
已完结
-
Brain metastasis in breast cancer: a comprehensive literature review
7个月前
已完结
-
Pyrotinib plus capecitabine for patients with human epidermal growth factor receptor 2-positive breast cancer and brain metastases (PERMEATE): a multicentre, single-arm, two-cohort, phase 2 trial
7个月前
已完结
-
Brain metastasis in patients with metastatic breast cancer in the real world: a single-institution, retrospective review of 12-year follow-up
8个月前
已完结